Tiny Gem Archives - Page 17 of 48

MondayDec 18, 2023 9:00 am

GEMXX Corp. (GEMZ) Reports Rise in Earnings, Assets, and Income in 2023, Prepares for Further Strategic Growth in Coming Year

GEMXX Corporation is a Las Vegas-based jewelry maker developing its strategic gold metal and ammolite gemstone from a unique mine-to-market product pipeline Gold has enjoyed record high prices during a “roaring 2023” run, and price fluctuations surrounding those highs have failed to deter optimism that demand for the precious metal may remain during the coming year GEMXX is the only publicly traded ammolite gemstone company in the world, and plans to expand its gemstone and jewelry production by 300 percent next year The company reported upbeat earnings and no long-term debt in its recent Q2 financial statement With the close…

WednesdayDec 13, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes Additional Revenue Opportunities for 2024; Continues to Generate New Data for its DehydraTECH Technology

Lexaria, a global innovator in drug delivery platforms, is projected by Zacks SCR to be valued at $10 a share, up from the current $1.50 for 2024 Zacks SCR projects a 259% YOY revenue growth for 2024 and a 20% growth for 2025, dependent upon the ultimate approval and commercialization of products employing its patented DehydraTECH(TM) technology Lexaria also anticipates FDA approval for its IND application and commence its Phase 1b hypertension clinical trial, all in 2024 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has had significant developments in 2023. Most notably, the company has seen…

MondayDec 11, 2023 9:45 am

Growth in Tokenized Securities Space, Growth of Diamond Lake Minerals Inc. (DLMI) Digital Asset-based Market Cap on Parallel Tracks

Security tokens and tokenized securities are gaining attention as the drivers of evolution in companies’ investment platforms, but the two digital offerings have distinct qualities that explain their differing trajectories Tokenized securities’ links to specific off-chain assets and mimicry of established asset groups have thus far given them the advantage over the broader base of investment in security tokens that has attracted the attention of SEC regulation enforcers Utah-based Diamond Lake Minerals is building a portfolio of vertically integrated, industry-agnostic subsidiaries dedicated to regulatory compliance while opening doors to digital assets for traditional investors wary of digital assets DLMI’s strategy…

ThursdayDec 07, 2023 10:30 am

GEMXX Corp. (GEMZ) Releases Positive Q2 2023 Results, Provides 2023 Business and Mining Updates

GEMXX reported significant growth in its Q2 2023 revenue and net income, with the company anticipating additional growth and increased production of its gold assets in 2024 GEMXX, in partnership with Crazy Horse Mining Inc., proved the commercial viability of the Snow Creek gold mine and is looking to similarly prove the viability of the Rosella Creek gold asset in 2024 For the balance of 2023 and into 2024, the company is targeting additional acquisitions, more mine production, and more revenues, and plans to expand gemstone and jewelry production by 300% in 2024 GEMXX (OTC: GEMZ), a company specializing in…

WednesdayDec 06, 2023 11:15 am

Podcast: Jewelry Maker GEMXX Corp. (GEMZ) Enjoys Rapid Growth Thanks to Gold Interest, Focus on Vertical Mine-to-Market Integration

GEMXX Corporation is unique as a jewelry maker with important Canadian mining assets, supporting its mine-to-market operations dealing in gold and the rare Ammolite gemstone Amid recent market fluctuations, gold continues to maintain a strategic profile as an investment safe haven, with consumption continuing at a historic pace GEMXX is riding high on recent “explosive” revenue growth and a no long-term debt position, looking forward to fulfilling select goals to improve its overall production, uplisting to a major exchange and aggressively seeking out strategic acquisitions to add revenue and / or reduce its costs A new NetworkNewsAudio News Podcast and…

TuesdayDec 05, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Results in Ongoing GLP-1 Human Pilot Study

Lexaria, a global innovator in drug delivery platforms, just announced additional positive interim results from its ongoing GLP-1 human pilot study The study seeks to provide an early-stage indication of whether DehydraTECH(TM) processing could improve oral drug delivery characteristics of the GLP-1 drug semaglutide Lexaria’s DehydraTECH GLP-1 showed a 2.9% to 14.6% blood glucose level reduction relative to baseline, compared to 1.3% to 6.7% for the control group The DehydraTECH GLP-1 group also only saw a 5.3% spike in glucose levels after having a standardized meal at the 240-minute mark and a snack at the 360-minute mark, compared to 22.7%…

MondayDec 04, 2023 10:30 am

Diamond Lake Minerals Inc. (DLMI) Riding Growing Sea Swell Favoring Digital Assets, Security Tokens

Security tokens are becoming increasingly popular as minimized risk entry points for digital infrastructure markets, with smart algorithms beginning to effectively deal with redemption dispute resolution concerns Utah-based Diamond Lake Minerals recently shifted its focus from mining holdings to digital assets and security tokens offerings, and has seen its market interest rise in the process DLMI aims to build an industry-agnostic, vertically integrated holding company that helps its subsidiaries develop self-sufficiency while offering an inroad to experienced investors wary of digital asset involvement — functioning as a “generational wealth” bridge Some market insiders see tokenization as the launch of a…

FridayDec 01, 2023 9:45 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Is ‘One to Watch’

In November 2023, Vision Marine filed with the SEC to sell 370,000 ordinary shares priced at $4.05 in a private placement The company in November 2023 reported its receipt of a purchase order from boat manufacturer Wired Pontoons for 25 units of its E-Motion 180E powertrain system Vision Marine announced in October 2023 delivery of E-Motion 180E powertrain technology to boat manufacturer Groupe Beneteau, to be integrated on the Four Winns H2e Bowrider model In August 2023, a catamaran powered by a Vision Marine powertrain set an electric boat world speed record of 116 mph at the Lake of the…

FridayDec 01, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Building a Global Presence with Superior Delivery Technology for Wide Range of Drugs and Active Pharmaceutical Ingredients

Lexaria, a global innovator in drug delivery platforms, has, through its patented DehydraTECH(TM) technology, proven to enhance the performance of several categories of fat-soluble active molecules and drugs Since 2018, human clinical studies on the technology have yielded positive results, ultimately earning Lexaria 37 granted patents globally, with many more pending around the world With the strides made so far, Lexaria looks to grow its revenue and commercial opportunities through licensing Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains committed to its mission to provide healthier delivery methods of drugs and other Active Pharmaceutical Ingredients (“APIs”).…

WednesdayNov 22, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer

Genprex was granted orphan drug designation by the FDA earlier this year for development of REQORSA combined with Tecentriq in small cell lung cancer Use of REQORSA combined with Tecentriq is the subject of Genprex’s upcoming Acclaim-3 clinical trial Genprex took part in two events in October – the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; and Genprex’s own hosted event, a Virtual Key Opinion Leaders on Bringing Gene Therapy to the Fight Against Lung Cancers Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes, was…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Category: Tiny Gem